George B. Abercrombie - Apr 18, 2022 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Alane P. Barnes, by power of attorney
Stock symbol
BCRX
Transactions as of
Apr 18, 2022
Transactions value $
-$38,600
Form type
4
Date filed
4/20/2022, 04:23 PM
Previous filing
Feb 16, 2022
Next filing
Jun 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Options Exercise $16.6K +5K $3.32 5K Apr 18, 2022 Direct F1
transaction BCRX Common Stock Sale -$55.2K -5K -100% $11.04 0 Apr 18, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCRX Automatic Stock Option Grant Options Exercise $0 -5K -100% $0.00* 0 Apr 18, 2022 Common Stock 5K $3.32 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021.
F2 The option vested 1/12 per month for a period of 12 months, beginning on June 23, 2012.